Introduction
============

Over the last two decades, morphological cardiac changes induced by athletic conditioning have been of great interest.[@b1-ijgm-5-655] Several studies have been orchestrated to delineate features of the athlete's heart such as left ventricular (LV) and left atrial remodelling.[@b2-ijgm-5-655] Accordingly, relevant studies are still being performed using electrocardiography (ECG) and/or echocardiography to further shed light on these issues. Among these, some researchers have targeted their studies at comparing ECG and/or echocardiographic findings between dynamic (endurance) and static (strength) athletes.[@b3-ijgm-5-655]--[@b6-ijgm-5-655] However, some contrasting results exist in the literature in this regard.[@b7-ijgm-5-655]

Furthermore, exercise is believed to alter a sympathovagal balance of the sinus node contributing in part to the heart rate changes in athletes.[@b8-ijgm-5-655] Nonetheless, it remains controversial whether these alterations in the autonomic function at rest, which is usually presented as bradycardia, are caused by attenuation of sympathetic tone and/or by enhanced vagal activity.[@b9-ijgm-5-655] Therefore, related investigations use heart rate variability (HRV) as a noninvasive method of providing information about vagal and sympathetic effects on the heart.[@b10-ijgm-5-655] To the best of the authors' knowledge, no single study has been hitherto performed to evaluate ECG, echocardiography, and HRV findings among athletes. Therefore, the aim of this study was to assess the ECG, echocardiography, and HRV in a group of Iranian dynamic and static type athletes and compare the related findings with those of healthy controls.

Methods
=======

Between April 2010 and April 2011, 50 professional Iranian athletes introduced by the Physical Education Organization (Tehran, Iran) and 50 healthy nonathletes (as the control group) were recruited. The study was approved by the local medical ethical committee of Tabriz University of Medical Sciences (Tabriz, Iran). Informed consent was obtained from all participants prior to the study. The inclusion criteria were being a professional athlete; lack of any history of structural cardiac, cerebrovascular, chronic renal or hepatic diseases, malignancy, and pregnancy; and willingness to participate in the study.

Standard 12-lead ECG was performed on all athletes and the control group in the supine position after a few minutes of rest during quiet respiration and recorded at 25 mm/second. Thereafter, in the ECG analysis particular attention was paid to heart rate (beats/minute), PR interval (milliseconds), QRS duration (milliseconds), QT interval corrected for the heart rate (milliseconds), QT dispersion (difference between maximum and minimum QT interval) (seconds), P-wave morphologic abnormality (P-wave duration \> 120 milliseconds as measured in the lead with the widest P-wave, amplitude \> 0.25 mV, and terminal negative deflection in the right precordial leads \>0.1 mV in depth), presence of Q-waves (≥2 mm in depth in at least two leads), R amplitude in precordial leads (V~1~ and V~5~) (mm), Sokolow--Lyon voltage criterion for LV hypertrophy (SV~1~ + RV~5~ \> 3.5 mV), and T-wave inversion (≥2 mm in depth in at least two contiguous leads, with the exclusion of leads III and augmented vector right). In addition, all athletes and the control group underwent transthoracic echocardiography and related features including LV ejection fraction (LVEF), LV end-diastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV mass, left atrial volume index (LAVI), early mitral filling velocity/early diastolic mitral annular velocity ratio, and pulmonary arterial pressure (PAP) were recorded and evaluated.[@b11-ijgm-5-655],[@b12-ijgm-5-655] Moreover, both the athletes and the control group underwent ECG Holter monitoring for 15 minutes, and several parameters related to HRV including standard deviation of the normal-to-normal intervals and the square root of the mean squared difference of successive normal-to-normal intervals were recorded. Regarding the frequency domain, low frequency, high frequency, very low frequency, and ultra-low frequency were evaluated as well. ECG Holter monitoring was performed in the morning after 30 minutes of supine rest and the studied individuals had abstained from exercise for 12 hours (the night before testing). The sampling rate of the Holter monitors was 500 Hz. The Holter images were scanned and analyzed with AB-180R Holter monitoring system (Advanced Biosensor Inc, Columbia, SC) after being manually edited to eliminate ectopic beats and noise signals by an experienced electrophysiologist (BK). The results of short-term recordings have been shown to correlate well with 24-hour recordings and are suitable for measuring changes over time.[@b13-ijgm-5-655] Furthermore, the prognostic value of short-term Holter recordings has been demonstrated for traditional HRV parameters.[@b14-ijgm-5-655],[@b15-ijgm-5-655]

Data are presented as mean ± standard deviation or as a percentage. All statistical analyses were performed with IBM^®^ SPSS for Windows version 17 (SPSS Inc, Chicago, IL). To analyze the measured quantitative variables between the studied groups, one-way analysis of variance was applied followed by an additional post hoc test in cases of significance. To study the frequency changes of the qualitative variables, Chi-squared test or Fisher's exact test were used. A *P* value less than 0.05 was considered statistically significant.

Results
=======

In this study, 100 people with a mean age of 27.8 ± 10.6 years (range: 20--35 years) were recruited: 50 healthy nonathletes (control group) and 50 professional athletes. The professional athletes group consisted of 20 professional athletes in the field of static exercise (eg, weightlifting and body building) and 30 professional athletes in the field of dynamic exercise (eg, swimming, soccer, track and field, badminton). There was no difference in gender and age between the control and athletes group (*P* \> 0.05; [Table 1](#t1-ijgm-5-655){ref-type="table"}). Classical underlying risk factors for cardiac diseases and cardiac symptoms of the studied participants are presented in [Table 1](#t1-ijgm-5-655){ref-type="table"}.

No significant difference was observed in the abnormal cases of ECG between the athletes and the control group; abnormal findings were present in 17 cases (34%) of the athletes group and 14 cases (20%) of the control group. The ECG qualitative and quantitative findings obtained from both groups are presented in [Table 2](#t2-ijgm-5-655){ref-type="table"}. Among the ECG quantitative variables, there was a statistically significant difference regarding R-wave amplitude between static, dynamic, and control groups; the static athletes showed the highest R-wave amplitude (*P* \< 0.001).

The findings of the transthoracic echocardiography are presented in [Table 3](#t3-ijgm-5-655){ref-type="table"}. LVEDD of the dynamic athletes was significantly greater than that of the control and static groups (*P* \< 0.001). In addition, LVESD of the static group was significantly lower than that of the control and dynamic groups (*P* \< 0.001). Furthermore, LV mass of the dynamic and static athletes was significantly greater than that of the controls (*P* \< 0.001). On the other hand, LAVI in the dynamic athletes was significantly higher than that in the control and static groups (*P* \< 0.001 and *P* = 0.001, respectively). There were no differences in other echocardiographic variables including LVEF, early mitral filling velocity/early diastolic mitral annular velocity ratio, and PAP between the groups ([Table 3](#t3-ijgm-5-655){ref-type="table"}; *P* \> 0.05).

Among the findings obtained from the ECG Holter monitoring, heart rate and systolic blood pressure at rest were significantly different between the studied groups. The dynamic athletes had lower systolic blood pressure than the controls (*P* = 0.01; [Table 4](#t4-ijgm-5-655){ref-type="table"}). Moreover, the heart rate was lowest in the control group compared with that in the dynamic and static athletes (*P* \< 0.001; [Table 4](#t4-ijgm-5-655){ref-type="table"}). There were no differences in HRV parameters, both time and frequency domain, between the groups ([Table 4](#t4-ijgm-5-655){ref-type="table"}; *P* \> 0.05).

Discussion
==========

In recent years, numerous medical reports have been describing diverse changes in ECG of professional athletes, most of which are due to a physiological adaptation of the athlete's heart to the conditions associated with physical activities.[@b16-ijgm-5-655],[@b17-ijgm-5-655] Abnormal ECG is more frequent among athletes compared with nonathletes, with a wide range of changes varying from 10%--50%.[@b16-ijgm-5-655] In a study carried out by Sharma et al studying the ECG changes between athletes and nonathletes, sinus bradycardia and sinus arrhythmia were reported in 80% and 52% of the athletes, respectively.[@b18-ijgm-5-655] Magalski et al highlighted that the most important ECG abnormalities accompanied with a high risk in athletes are deep Q-wave and inverted T-wave, which were, however, rare (\<5%).[@b19-ijgm-5-655] Deep inverted T-waves are one of the most important alarming indicators of cardiomyopathy in athletes.[@b20-ijgm-5-655] In the current study, deep Q-wave and inverted T-wave was present in 2% of the athletes, each accounting for a very low percentage of the abnormal ECG findings in athletes. This finding is similar to that of previous studies.[@b19-ijgm-5-655],[@b21-ijgm-5-655] Consistent with previous studies, the most common ECG finding in the current study was sinus bradycardia.[@b18-ijgm-5-655],[@b20-ijgm-5-655],[@b22-ijgm-5-655] There is a consensus on the most common ECG changes in athletes: sinus bradycardia, first degree heart block, and incomplete right bundle branch block.[@b23-ijgm-5-655] Similarly, sinus bradycardia and incomplete right bundle branch block were the most common ECG abnormalities in the athletes group of the current study. Furthermore, tall R-wave was only detected in the static athletes, which is consistent with the findings of Bialy et al's study.[@b24-ijgm-5-655] This finding is suggestive of cardiac adaptation of the static athletes for their particular type of exercise, ie, strength training exercises.

Previous studies have confirmed that adaptive changes of the heart muscle, such as symmetrical hypertrophy and cardiac volume changes, are based on the exercise activity of the athletes, and hemodynamic changes and requirements are the major factors contributing to the changes in the heart muscle and structure of the heart in athletes.[@b25-ijgm-5-655] In an echocardiographic study of athletes performed by Bialy et al LV mass of the dynamic athletes increased compared with the nonathletes.[@b24-ijgm-5-655] In the current study, LV mass of dynamic and static athletes was significantly greater than that in nonathletes. This finding was previously reported by Abinader et al[@b26-ijgm-5-655] and D'Andrea et al.[@b3-ijgm-5-655] Although the current study did not result in a difference between static and dynamic athletes with regard to LV mass, Venckunas et al indicated that LV mass was lower in static athletes compared with dynamic athletes.[@b7-ijgm-5-655] During dynamic exercise, the LV withstands repetitive stress, which leads to an increase in LV mass. In addition, the current study revealed that LVESD was lower in static athletes and LVEDD was greater in dynamic athletes considering their increased hemodynamic requirements. Abinader et al[@b26-ijgm-5-655] and D'Andrea et al[@b5-ijgm-5-655],[@b6-ijgm-5-655],[@b27-ijgm-5-655] reported similar findings in this regard. Moreover, in the current study, LAVI was significantly greater in the dynamic athletes compared with the static athletes and nonathletes. This finding is similar to that of previous studies by D'Andrea et al.[@b27-ijgm-5-655]--[@b29-ijgm-5-655] In addition, the current results indicate similar LVEF values in the nonathletes, static athletes, and dynamic athletes. Likewise, D'Andrea et al found no difference between the static and dynamic groups with regard to LVEF.[@b5-ijgm-5-655],[@b6-ijgm-5-655],[@b27-ijgm-5-655]--[@b29-ijgm-5-655] Furthermore, the current study failed to detect any difference in PAP between the studied groups. In contrast, recent investigations by D'Andrea et al indicate a higher PAP in dynamic athletes.[@b4-ijgm-5-655],[@b6-ijgm-5-655]

One of the long-term effects of exercise is a positive increase in parasympathetic activities in the autonomic nervous system, which can be traced using parameters such as standard deviation of the normal-to-normal intervals (HRV) and square root of the mean squared difference of successive normal-to-normal intervals.[@b25-ijgm-5-655] During dynamic exercise, the heart rate increases which is due to parasympathetic blockade and increase in sympathetic activity; however, the dominance of the parasympathetic system is significant in athletes.[@b30-ijgm-5-655] The current study revealed that the heart rate and systolic blood pressure at rest were lower in the athletes compared with the control group. These findings are similar to those of previous studies.[@b24-ijgm-5-655],[@b31-ijgm-5-655],[@b32-ijgm-5-655] With regard to the HRV parameters, previous studies indicated a significant increase in HRV in professional athletes.[@b31-ijgm-5-655]--[@b33-ijgm-5-655] In other studies on the autonomic nervous system using HRV analysis, a shift in the cardiac autonomic balance towards the dominance of the sympathetic system was noted.[@b34-ijgm-5-655]--[@b36-ijgm-5-655] On the other hand, in a study carried out by Raczak et al, no increase in adrenergic activity was reported despite an increase in activity.[@b25-ijgm-5-655] Lower sample sizes in previous studies may have contributed to the observed differences in results. In the current study, no significant difference was observed between the athletes and nonathletes regarding HRV. The sampling rate of Holter monitoring was 500 Hz in the current study, a rate sufficient for measuring very low frequency, low frequency, and high frequency domains of HRV during short-term recording.[@b37-ijgm-5-655] However, the measurement of ultra low frequency requires more recording time. This can be regarded as a limitation in the current study.

Conclusion
==========

The present investigation found that the most common ECG abnormalities among adolescent Iranian athletes were sinus bradycardia and incomplete right bundle branch block. In addition, according to their increased hemodynamic requirements, static exercise seemed to reduce LVESD. On the other hand, dynamic exercise resulted in increased LVEDD diameter and LAVI. Additionally, Iranian athletes showed no differences in HRV parameters, excluding heart rate and systolic blood pressure, compared with the nonathletes.
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###### 

Demographic data and cardiovascular risk factors of the studied groups

  **Variable**                                **Control group (n = 50)**   **Static group (n = 20)**   **Dynamic group (n = 30)**   ***P* value**
  ------------------------------------------- ---------------------------- --------------------------- ---------------------------- ---------------
  Age (years)                                 26.5 ± 4.7                   26.2 ± 4.4                  26.7 ± 4.02                  0.89
  Family history of cardiovascular diseases   3 (6%)                       0 (0)                       2 (6%)                       NA
  Smoking                                     5 (10%)                      4 (8%)                      0 (0)                        NA
  Hyperlipidemia                              3 (6%)                       2 (10%)                     0 (0)                        NA
  Diabetes mellitus                           0 (0)                        0 (0)                       0 (0)                        NA
  Palpitation                                 6 (12%)                      3 (15%)                     1 (3)                        NA
  Dizziness                                   3 (6%)                       1 (5%)                      1 (3%)                       NA
  Chest pain                                  0 (0)                        0 (0)                       0 (0)                        NA
  History of syncope                          0 (0)                        0 (0)                       0 (0)                        NA

**Note:** Data presented as either mean ± standard deviation or n (%).

**Abbreviation:** NA, not available.

###### 

Electrocardiographic findings in the studied groups

  **Variable**                                    **Control group (n = 50)**   **Static group (n = 20)**   **Dynamic group (n = 30)**   ***P* value**
  ----------------------------------------------- ---------------------------- --------------------------- ---------------------------- -----------------------------------------------------
  QTc interval (milliseconds)                     401.78 ± 25.61               399.93 ± 29.61              393.18 ± 32.46               0.42
  QT dispersion (seconds)                         0.03 ± 0.003                 0.03 ± 0.004                0.05 ± 0.07                  0.12
  QRS complex duration (milliseconds)             72.01 ± 12.46                72.32 ± 11.82               72.5 ± 11.44                 0.98
  R amplitude (mm)                                15.73 ± 4.29                 27.27 ± 5.66                17.94 ± 4.66                 \<0.001[^a^](#tfn4-ijgm-5-655){ref-type="table-fn"}
  Sinus bradycardia (HR \< 60 beats/minute)       8 (16%)                      10 (50%)                    13 (43%)                     0.03[^b^](#tfn5-ijgm-5-655){ref-type="table-fn"}
  Premature ventricular contraction               4 (8%)                       3 (15%)                     4 (13.3%)                    NA
  R amplitude \> 35 mm                            0 (0)                        3 (15%)                     0 (0)                        NA
  Inverted T-waves                                0 (0)                        1 (5%)                      0 (0)                        NA
  Heart block (PR interval \> 120 milliseconds)   0 (0)                        1 (5%)                      1 (3.3%)                     NA
  P morphology (RAA)                              3 (6%)                       2 (10%)                     6 (20%)                      NA
  P morphology (LAA)                              2 (4%)                       2 (10%)                     1 (3.3%)                     NA
  Q-waves                                         0 (0)                        1 (5%)                      0 (0)                        NA
  Incomplete RBBB                                 10 (20%)                     6 (30%)                     11 (36.6%)                   0.04[^c^](#tfn6-ijgm-5-655){ref-type="table-fn"}

**Notes:** Data presented as either mean ± standard deviation or n (%).

Control versus static (*P* \< 0.001), static versus dynamic (*P* = 0.001);

control versus static (*P* = 0.01) and dynamic (*P* = 0.03);

control versus static (*P* = 0.04) and dynamic (*P* = 0.03).

**Abbreviations:** HR, heart rate; LAA, left atrial appendage; NA, not available; QTc, QT interval corrected for the heart rate; RAA, right atrial appendage; RBBB, right bundle branch block.

###### 

Echocardiographic variables in the studied groups

  **Variable**       **Control group (n = 50)**   **Static group (n = 20)**   **Dynamic group (n = 30)**   ***P* value**
  ------------------ ---------------------------- --------------------------- ---------------------------- ------------------------------------------------------
  LVEF (%)           59.18 ± 3.6                  61.55 ± 4.5                 61.50 ± 3.3                  0.09
  LVEDD (cm)         4.49 ± 0.38                  4.71 ± 0.43                 5.4 ± 0.32                   \<0.001[^a^](#tfn9-ijgm-5-655){ref-type="table-fn"}
  LVESD (cm)         3.18 ± 0.32                  2.81 ± 0.33                 3.36 ± 0.38                  \<0.001[^b^](#tfn10-ijgm-5-655){ref-type="table-fn"}
  LV mass (g)        154.5 ± 29                   224.6 ± 40.3                225.8 ± 51.2                 \<0.001[^c^](#tfn11-ijgm-5-655){ref-type="table-fn"}
  LAVI (mL/m^2^)     31.35 ± 5.64                 35.47 ± 12.11               45.49 ± 11.36                \<0.001[^d^](#tfn12-ijgm-5-655){ref-type="table-fn"}
  E/E′ (cm/second)   5.02 ± 0.44                  5.01 ± 0.69                 4.65 ± 1.06                  0.07

**Notes:** Data presented as mean ± standard deviation.

Control versus static (*P* \< 0.001) and dynamic (*P* \< 0.001), static versus dynamic (*P* \< 0.001);

control versus static (*P* \< 0.001) and dynamic (*P* \< 0.001), static versus dynamic (*P* \< 0.001);

control versus static (*P* \< 0.001) and dynamic (*P* \< 0.001);

control versus dynamic (*P* \< 0.001), static versus dynamic (*P* = 0.001).

**Abbreviations:** E/E′, early mitral filling velocity/early diastolic mitral annular velocity ratio; LAVI, left atrial volume index; LV mass, left ventricular mass; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter.

###### 

Heart rate variability variables in the studied groups

  **Variable**                      **Control group (n = 50)**   **Static group (n = 20)**   **Dynamic group (n = 30)**   ***P* value**
  --------------------------------- ---------------------------- --------------------------- ---------------------------- ------------------------------------------------------
  Systolic blood pressure (mmHg)    127.34 ± 7.3                 123.75 ± 13.16              120.42 ± 11.78               0.01[^a^](#tfn15-ijgm-5-655){ref-type="table-fn"}
  Diastolic blood pressure (mmHg)   78.1 ± 8.7                   79.3 ± 11.1                 74.59 ± 7.5                  0.13
  Heart rate (beats/minute)         73.4 ± 7.76                  61.9 ± 8.38                 58.86 ± 8.68                 \<0.001[^b^](#tfn16-ijgm-5-655){ref-type="table-fn"}
  SDNN (milliseconds)               72.22 ± 27.29                75.68 ± 44.68               74.67 ± 26.58                0.89
  RMSSD (milliseconds)              46.88 ± 31.24                59.18 ± 37.46               65.79 ± 40.51                0.06
  HRV index                         15.47 ± 3.89                 15.37 ± 5.08                16.38 ± 3.4                  0.56
  ULF (Hz)                          46.43 ± 36.61                53.22 ± 37.18               49.07 ± 38.3                 0.78
  VLF (Hz)                          234.63 ± 78.7                215.5 ± 85.49               213.1 ± 84.12                0.45
  LF (Hz)                           225.3 ± 64.37                228.35 ± 73.28              224.43 ± 72.54               0.1
  HF (Hz)                           131.75 ± 53.49               122.99 ± 35.18              126.06 ± 35.75               0.73

**Notes:** Data presented as mean ± standard deviation.

Control versus dynamic (*P* = 0.01);

control versus static (*P* \< 0.001) and dynamic (*P* \< 0.001).

**Abbreviations:** HF, high frequency; HRV, heart rate variability; LF, low frequency; RMSSD, square root of the mean squared difference of successive normal-to-normal intervals; SDNN, standard deviation of the normal-to-normal intervals; ULF, ultra-low frequency; VLF, very low frequency.
